Phenotypic clustering in MPZ mutations

被引:220
作者
Shy, ME
Jáni, A
Krajewski, K
Grandis, M
Lewis, RA
Li, J
Shy, RR
Balsamo, J
Lilien, J
Garbern, JY
Kamholz, J
机构
[1] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA
[3] Childrens Hosp Michigan, Dept Pediat, Detroit, MI 48201 USA
[4] Univ Iowa, Dept Biol Sci, Iowa City, IA USA
关键词
MPZ; CMT1B; phenotype; myelin; PNS;
D O I
10.1093/brain/awh048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myelin protein zero (MPZ) is a member of the immunoglobulin gene superfamily with single extracellular, transmembrane and cytoplasmic domains. Homotypic interactions between extracellular domains of MPZ adhere adjacent myelin wraps to each other. MPZ is also necessary for myelin compaction since mice which lack MPZ develop severe dysmyelinating neuropathies in which compaction is dramatically disrupted. MPZ mutations in humans cause the inherited demyelinating neuropathy CMT1B. Some mutations cause the severe neuropathies of infancy designated as Dejerine-Sottas disease, while others cause a 'classical' Charcot-Marie-Tooth (CMT) disease Type 1B (CMT1B) phenotype with normal early milestones but development of disability during the first two decades of life. Still other mutations cause a neuropathy that presents in adults, with normal nerve conduction velocities, designated as a 'CMT2' form of CMT1B. To correlate the phenotype of patients with MPZ mutations with their genotype, we identified and evaluated 13 patients from 12 different families with eight different MPZ mutations. In addition, we re-analysed the clinical data from 64 cases of CMT1B from the literature. Contrary to our expectations, we found that most patients presented with either an early onset neuropathy with signs and symptoms prior to the onset of walking or a late onset neuropathy with signs and symptoms at around age 40 years. Only occasional patients presented with a 'classical' CMT phenotype. Correlation of specific MPZ mutations with their phenotypes demonstrated that addition of either a charged amino acid or altering a cysteine residue in the extracellular domain caused a severe early onset neuropathy. Severe neuropathy was also caused by truncation of the cytoplasmic domain or alteration of an evolutionarily conserved amino acid. Taken together, these data suggest that early onset neuropathy is caused by MPZ mutations that significantly disrupt the tertiary structure of MPZ and thus interfere with MPZ-mediated adhesion and myelin compaction. In contrast, late onset neuropathy is caused by mutations that more subtly alter myelin structure and which probably disrupt Schwann cell-axonal interactions.
引用
收藏
页码:371 / 384
页数:14
相关论文
共 83 条
  • [41] Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy
    Mastaglia, FL
    Nowak, KJ
    Stell, R
    Phillips, BA
    Edmondston, JE
    Dorosz, SM
    Wilton, SD
    Hallmayer, J
    Kakulas, BA
    Laing, NG
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (02) : 174 - 179
  • [42] Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B
    Matsuyama, W
    Nakagawa, M
    Takashima, H
    Osame, M
    [J]. ACTA NEUROPATHOLOGICA, 2002, 103 (05) : 501 - 508
  • [43] Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies
    Meijerink, PHS
    Hoogendijk, JE
    GabreelsFesten, AAWM
    Zorn, I
    Veldman, H
    Baas, F
    deVisser, M
    Bolhuis, PA
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (04) : 672 - 675
  • [44] Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells
    Menichella, DM
    Arroyo, EJ
    Awatramani, R
    Xu, T
    Baron, P
    Vallat, JM
    Balsamo, J
    Lilien, J
    Scarlato, G
    Kamholz, J
    Scherer, SS
    Shy, ME
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 18 (06) : 606 - 618
  • [45] Misu K, 2000, Rinsho Shinkeigaku, V40, P149
  • [46] Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies
    Naef, R
    Suter, U
    [J]. NEUROBIOLOGY OF DISEASE, 1999, 6 (01) : 1 - 14
  • [47] A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths
    Nakagawa, M
    Suehara, M
    Saito, A
    Takashima, H
    Umehara, F
    Saito, M
    Kanzato, N
    Matsuzaki, T
    Takenaga, S
    Sakoda, S
    Izumo, S
    Osame, M
    [J]. NEUROLOGY, 1999, 52 (06) : 1271 - 1275
  • [48] Nelis E, 1996, EUR J HUM GENET, V4, P25
  • [49] THE HYPERTROPHIC FORMS OF HEREDITARY MOTOR AND SENSORY NEUROPATHY - A STUDY OF HYPERTROPHIC CHARCOT-MARIE-TOOTH DISEASE (HMSN TYPE-I) AND DEJERINE-SOTTAS DISEASE (HMSN TYPE-III) IN CHILDHOOD
    OUVRIER, RA
    MCLEOD, JG
    CONCHIN, TE
    [J]. BRAIN, 1987, 110 : 121 - 148
  • [50] Heterozygous null mutation in the P0 gene associated with mild Charcot-Marie-Tooth disease
    Pareyson, D
    Menichella, D
    Botti, S
    Sghirlanzoni, A
    Fallica, E
    Mora, M
    Ciano, C
    Shy, ME
    Taroni, F
    [J]. CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 477 - 480